focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrooks Macdonald Regulatory News (BRK)

Share Price Information for Brooks Macdonald (BRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,990.00
Bid: 2,000.00
Ask: 2,060.00
Change: -40.00 (-1.97%)
Spread: 60.00 (3.00%)
Open: 2,020.00
High: 2,020.00
Low: 1,990.00
Prev. Close: 2,030.00
BRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Tritax Big Box REIT plc

1 Mar 2024 13:21

RNS Number : 3067F
Brooks Macdonald Group PLC
01 March 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Brooks Macdonald Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Tritax Big Box REIT plc

 

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

29 February 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, UK Commercial Property REIT Limited

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

9,934,966

0.52

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

9,934,966

0.52

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

1p ordinary

Sale

5,426

1.48 GBP

1p ordinary

Sale

22,890

1.49 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

01 March 2024

Contact name:

Birute Salinaite

Telephone number*:

0207 9274 952

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFLFLVVAILIIS
Date   Source Headline
2nd Dec 20194:06 pmRNSTotal Voting Rights
28th Nov 20192:12 pmRNSHolding(s) in Company
22nd Nov 20192:55 pmRNSDirector/PDMR Shareholding
22nd Nov 20192:25 pmRNSResult of placing
22nd Nov 20197:00 amRNSProposed placing to raise approximately £30m
22nd Nov 20197:00 amRNSAcquisition of Cornelian Asset Managers
5th Nov 20195:52 pmRNSHolding(s) in Company
31st Oct 20194:37 pmRNSTotal Voting Rights
31st Oct 20194:26 pmRNSAGM Statement
24th Oct 20197:00 amRNSQuarterly Announcement of Funds under Management
30th Sep 20194:23 pmRNSTotal Voting Rights
12th Sep 20197:00 amRNSFinal Results
30th Aug 201912:40 pmRNSTotal Voting Rights
22nd Aug 20193:58 pmRNSNotice of Results
12th Aug 20194:58 pmRNSHolding(s) in Company
31st Jul 20191:08 pmRNSHolding(s) in Company
31st Jul 201910:54 amRNSTotal Voting Rights
25th Jul 20194:41 pmRNSEmployee Benefit Trust Dealing
24th Jul 20197:00 amRNSYear End Trading Update
17th Jul 20197:00 amRNSNew London Office
4th Jul 20191:18 pmRNSDirector/PDMR Shareholding
1st Jul 201910:24 amRNSTotal Voting Rights
20th Jun 201910:05 amRNSBlock listing Interim Review
17th Jun 20193:28 pmRNSHolding(s) in Company
14th Jun 201910:15 amRNSDirector/PDMR Shareholding
12th Jun 20194:41 pmRNSSecond Price Monitoring Extn
12th Jun 20194:35 pmRNSPrice Monitoring Extension
4th Jun 20191:40 pmRNSEBT Dealings
31st May 201910:44 amRNSTotal Voting Rights
30th May 20199:38 amRNSDirector/PDMR Shareholding
21st May 20194:40 pmRNSSecond Price Monitoring Extn
21st May 20194:35 pmRNSPrice Monitoring Extension
20th May 20199:58 amRNSDirector/PDMR Shareholding
15th May 20192:01 pmRNSEBT Dealings
15th May 20199:32 amRNSDirector/PDMR Shareholding
14th May 20197:00 amRNSBlock Listing Application
9th May 20199:09 amRNSEBT Dealings
30th Apr 20199:35 amRNSTotal Voting Rights
25th Apr 20197:00 amRNSQuarterly Announcement of Funds under Management
24th Apr 20195:40 pmRNSHolding(s) in Company
24th Apr 20193:51 pmRNSHolding(s) in Company
24th Apr 20191:10 pmRNSHolding(s) in Company
5th Apr 20195:22 pmRNSDirector/PDMR Shareholding
5th Apr 20191:01 pmRNSDirector/PDMR Shareholding
1st Apr 201911:15 amRNSTotal Voting Rights
28th Mar 20199:36 amRNSDirectorate Change
15th Mar 20193:41 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSHalf-year Report
28th Feb 201911:04 amRNSTotal Voting Rights
26th Feb 20191:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.